Milestone Pharmaceuticals shareholders elect directors, approve auditor and equity plan amendment at 2022 meeting

Milestone Pharmaceuticals Inc.

All six director nominees elected: Joseph Oliveto, Lisa M. Giles, Richard Pasternak, Debra K. Liebert, Michael Tomsicek, Robert J. Wills. Votes for each ranged 19,105,725 – 19,110,012.
PricewaterhouseCoopers LLP appointed as auditor for 2023 with 24,809,612 votes for, 0 against, 217,072 withheld.
Amendment to 2019 Equity Incentive Plan approved; increase of 1,000,000 shares authorized. 15,462,071 for, 3,652,167 against, 5,912,446 broker non-votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.